Federated Investors Inc. PA reduced its position in shares of STERIS PLC (NYSE:STE) by 7.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 42,421 shares of the medical equipment provider’s stock after selling 3,331 shares during the period. Federated Investors Inc. PA’s holdings in STERIS PLC were worth $3,457,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently made changes to their positions in STE. Russell Investments Group Ltd. raised its position in STERIS PLC by 57.5% during the first quarter. Russell Investments Group Ltd. now owns 132,035 shares of the medical equipment provider’s stock valued at $9,171,000 after purchasing an additional 48,188 shares in the last quarter. Oregon Public Employees Retirement Fund raised its position in STERIS PLC by 1.3% during the first quarter. Oregon Public Employees Retirement Fund now owns 30,160 shares of the medical equipment provider’s stock valued at $2,095,000 after purchasing an additional 400 shares in the last quarter. Canada Pension Plan Investment Board raised its position in STERIS PLC by 112.8% during the first quarter. Canada Pension Plan Investment Board now owns 38,100 shares of the medical equipment provider’s stock valued at $2,646,000 after purchasing an additional 20,200 shares in the last quarter. Great West Life Assurance Co. Can raised its position in STERIS PLC by 6.4% during the first quarter. Great West Life Assurance Co. Can now owns 129,784 shares of the medical equipment provider’s stock valued at $9,021,000 after purchasing an additional 7,839 shares in the last quarter. Finally, State Treasurer State of Michigan raised its position in STERIS PLC by 0.6% during the first quarter. State Treasurer State of Michigan now owns 34,500 shares of the medical equipment provider’s stock valued at $2,396,000 after purchasing an additional 200 shares in the last quarter. Institutional investors and hedge funds own 94.65% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This piece was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece on another website, it was copied illegally and reposted in violation of US and international copyright and trademark laws. The legal version of this piece can be read at https://www.thecerbatgem.com/2017/09/05/steris-plc-ste-shares-sold-by-federated-investors-inc-pa.html.

STERIS PLC (NYSE STE) opened at 86.88 on Tuesday. The stock’s 50 day moving average is $84.12 and its 200 day moving average is $76.81. STERIS PLC has a one year low of $63.80 and a one year high of $87.49. The firm has a market capitalization of $7.40 billion, a P/E ratio of 62.15 and a beta of 1.29.

STERIS PLC (NYSE:STE) last issued its earnings results on Tuesday, August 8th. The medical equipment provider reported $0.85 EPS for the quarter, topping analysts’ consensus estimates of $0.80 by $0.05. The company had revenue of $608 million for the quarter, compared to analysts’ expectations of $597.66 million. STERIS PLC had a net margin of 4.63% and a return on equity of 11.39%. The firm’s revenue was down 4.8% compared to the same quarter last year. During the same quarter last year, the company earned $0.79 EPS. On average, equities research analysts predict that STERIS PLC will post $4.06 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 28th. Investors of record on Tuesday, August 29th will be given a $0.31 dividend. This represents a $1.24 dividend on an annualized basis and a yield of 1.43%. The ex-dividend date of this dividend is Friday, August 25th. This is a boost from STERIS PLC’s previous quarterly dividend of $0.28. STERIS PLC’s dividend payout ratio (DPR) is presently 88.57%.

Several research analysts have commented on the stock. Zacks Investment Research downgraded shares of STERIS PLC from a “buy” rating to a “hold” rating in a research report on Tuesday, August 22nd. Raymond James Financial, Inc. boosted their price objective on shares of STERIS PLC from $90.00 to $95.00 and gave the company an “outperform” rating in a research report on Wednesday, August 9th. BidaskClub downgraded shares of STERIS PLC from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st. Finally, Wellington Shields downgraded shares of STERIS PLC from a “gradually accumulate” rating to a “hold” rating in a research report on Monday, June 5th. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $86.75.

In related news, Director Mohsen Sohi sold 2,744 shares of STERIS PLC stock in a transaction on Wednesday, August 9th. The shares were sold at an average price of $85.98, for a total value of $235,929.12. Following the transaction, the director now owns 21,816 shares in the company, valued at approximately $1,875,739.68. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Daniel A. Carestio sold 4,745 shares of STERIS PLC stock in a transaction on Tuesday, June 13th. The stock was sold at an average price of $80.08, for a total transaction of $379,979.60. The disclosure for this sale can be found here. In the last quarter, insiders sold 28,554 shares of company stock worth $2,390,238. 2.55% of the stock is owned by corporate insiders.

STERIS PLC Company Profile

STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS PLC (NYSE:STE).

Institutional Ownership by Quarter for STERIS PLC (NYSE:STE)

Receive News & Stock Ratings for STERIS PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS PLC and related stocks with our FREE daily email newsletter.